5 employees
Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer.
2020
$12M
from 2 investors over 2 rounds
Tachyon Therapeutics raised $12M on March 1, 2023
Investors: Khosla Ventures and Red Tree Venture Capital